Thyroid nodules and thyroid cancer in pregnancy.

Durairaj Arjunan, Zoran Gluvic, Sanja Medenica, Pinaki Dutta, Violeta Mladenovic, Nikola Zankovic, Slavica Aksam

Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2025;41(1):2517878

PMID: 40511591

Abstract

Thyroid gland size increases during pregnancy due to physiological changes. 2-3% of pregnancies, a thyroid nodule (TN) may either newly develop or an existing one may increase in size. Factors such as age, parity, and iodine status can influence the development of TN. Surveillance of TN in pregnancy is essentially similar to that of the general population as it is contraindicated. Fine needle aspiration cytology (FNAC) can be delayed until after delivery unless malignancy is suspected. Surgery is reserved for severe cases, those with rapid growth, or those with suspicious features. Surgery is typically performed during the second trimester. Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer during pregnancy, which ranks second among cancers affecting pregnant women. Given the challenges involved, the prognosis is still favorable, have minimal impact on survival rates or recurrence. Treatment guidelines suggest regular monitoring of TSH and thyroid ultrasound (TUS), ensuring careful management of TC, especially in cases of aggressive.

Address: Department of Endocrinology, Internal Medicine Clinic, Clinical Center of Montenegro, Podgorica, Montenegro.; Faculty of Medicine, University of Montenegro, Podgorica, Montenegro.; Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.; Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center Kragujevac, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.; Department of Endocrinology, Internal Medicine Clinic, Clinical Center of Montenegro, Podgorica, Montenegro.; Clinic for Gynecology and Obstetrics, Faculty of Medicine, Belgrade, Serbia.; Division of Internal Medicine, Department of Endocrinology, Clinical Hospital Center Zemun, Faculty of Medicine, University of Belgrade, Serbia.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.